Lung cancer is by far the deadliest cancer, representing nearly a quarter of all cancer deaths. However, there is good news: The incidence of lung cancer and…
Dr. Kaye is a professor of medicine, medical director of the thoracic oncology program and director of the lung cancer center within the division of hematology and oncology. He is a clinical and basic science investigator with a focus on thoracic malignancies. Dr. Kay is an elected member of the American Society for Clinical Investigation, the Alpha Omega Alpha medical honor society, and serves as Associate Editor of the Journal of the National Cancer Institute.
Top areas of exploration
- Lung Neoplasms , 47 publications
- Gene Expression Regulation, Neoplastic , 26 publications
- Mutation , 25 publications
- Transcription Factors , 25 publications
17,493 citationsWhy is this important?
Search our accepted insurances list
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
My areas of focus
Stories and news
February 11, 2015
A University of Florida Health patient has become the first person to receive a combination of oral therapies targeted to a specific gene mutation that has…
UF Health Cancer Center, +2 more